Genes & biomarkers

BRAF variants

BRAF · V600E / V600K

The BRAF variant and cancer type influence the treatment combination.

Sources checked · Introductory guide

On this page

What does this result mean?

BRAF transmits growth signals. Some variants, including V600E, can keep signaling active. Not all BRAF variants have the same behavior.[1]

How does it connect to treatment?

Combinations such as dabrafenib with trametinib are used in selected BRAF-altered melanomas and lung cancers. Colorectal cancer may need a different combination; regimens cannot simply be copied between cancers.[2]

What should I check in my report?

Distinguish V600E, V600K and non-V600 variants. Ask which combination has evidence for your cancer and whether treatment requires more than one drug.

Questions for your care team

  • Which combination fits my BRAF variant and cancer type?
  • Which treatments or trials fit my cancer type, stage and previous treatment?

Sources and scope

Source documents are in English.

Entries summarize and translate linked official public sources. The source-check date records when those sources were checked; it does not indicate a clinician’s review.

  1. MedlinePlus Genetics · BRAF (opens in a new tab)
  2. NCI · Dabrafenib (opens in a new tab)
  3. NCI · Cetuximab (opens in a new tab)

General information based on official public sources. This is not a complete list of uses or side effects. Individual treatment decisions require your care team and current source documents. US-source uses do not establish local approval or reimbursement.

Related entries

BRAF variants | Cancer Encyclopedia | My Chemo Diary